FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$183M
1-Year Est. Return
18.94%
1 Year Est. Return
+18.94%
AUM
$183M
AUM Growth
+$58.8M
(+48%)
Holding
7
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pharvaris
PHVS
$1.74B
| $119M | 65.29% |
4,778,581
+368,000
|
|
||
2
Cytokinetics
CYTK
$8.07B
| $25.2M | 13.79% |
+458,295
|
|
||
|
MAZE
3
Maze Therapeutics
MAZE
$2.01B
| $13.6M | 7.42% |
522,657
-1,589,262
|
|
||
4
Lyell Immunopharma
LYEL
$533M
| $13M | 7.12% |
800,399
|
|
||
5
Xenon Pharmaceuticals
XENE
$3.48B
| $6.42M | 3.52% |
160,000
|
|
||
6
Relay Therapeutics
RLAY
$1.33B
| $5.22M | 2.86% |
1,000,000
|
|
||
7
Kura Oncology
KURA
$1.03B
| – | – |
-816,882
|
|